| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | SVP, Controller And Pao | VP, Controller And Pao +1 more
1 company
Huizenga Theodore Alan is a SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 85 | $34.38 | $2,922.30 | -0.2% | -2.1% | - | |
| Sep 18, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 64 | $29.17 | $1,866.88 | -0.1% | +14.1% | - | |
| Sep 5, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 84 | $31.39 | $2,636.76 | -0.2% | +14.8% | - | |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 967 | $42.10 | $40,710.70 | -1.9% | -12.4% | -46.5% | |
| Sep 3, 2024 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 91 | $56.19 | $5,113.29 | -0.2% | -14.6% | -43.4% | |
| Mar 1, 2024 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 341 | $53.76 | $18,332.16 | -0.8% | -28.0% | -20.1% | |
| Sep 7, 2023 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sale+OE | 2,163 | $40.80 | $88,249.42 | -4.4% | -0.1% | +34.3% | |
| Sep 1, 2023 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 970 | $37.15 | $36,032.33 | -2.0% | +2.8% | +50.3% | |
| Mar 1, 2023 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 100 | $45.65 | $4,565.00 | -0.4% | +6.0% | +13.3% | |
| Feb 28, 2023 | RARE Ultragenyx Pharmaceutical Inc. | SVP, Chief Accounting Officer | Sell | 639 | $43.40 | $27,732.60 | -3.9% | +8.8% | +18.6% |